首页|University Health Network and the University of Toronto Reports Findings in Testicular Cancer (Propensity-matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for Clinical Stage Ⅱ Testicular Cancer)
University Health Network and the University of Toronto Reports Findings in Testicular Cancer (Propensity-matched Analysis of Open Versus Robotic Primary Retroperitoneal Lymph Node Dissection for Clinical Stage Ⅱ Testicular Cancer)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
New research on Oncology - Testicular Cancer is the subject of a report. According to news originating from Toronto, Canada, by NewsRx correspondents, research stated, “Open retroperitoneal lymph node dissection (O-RPLND) is the accepted standard surgical approach to treat retroperitoneal nodal disease in testis cancer. Increasingly, robotic RPLND (R-RPLND) is being performed due to the potential for lower blood loss, shorter length of stay, and accelerated recovery.”
TorontoCanadaNorth and Central AmericaCancerEmerging TechnologiesHealth and MedicineHemic and Immune SystemsImmunologyLymph NodesLymphoid TissueMachine LearningOncologyRoboticsRobotsTesticular CancerTesticular Diseases and Conditions
NETL
NSTL
